Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2036

Annual patent cliff calendar for 2036 — US pharmaceutical patents by expiration date.

Patents
1,428

Quick answer

1,428 indexed pharmaceutical patents have expiration dates in 2036. Browse by soonest expiry with links to assignee companies and related drugs.

  1. EP 2961422

    THERAPEUTIKUM FÜR FRUCHTWASSEREMBOLIE

    CSL BEHRING GMBH [DE] · Granted Wed Jan 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Jan 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. AU 2014283378

    2,3-dihydrobenzofuran-5-yl compounds as DYRK kinase inhibitors

    4SC DISCOVERY GMBH [DE] · Granted Thu Jan 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jan 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. WO 2016001312

    DISPOSITIF POUR LA FABRICATION DE TIMBRES PHARMACEUTIQUES

    ACINO AG [DE] · Granted Thu Jan 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jan 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9233131

    Mutant adeno-associated virus virions and methods of use thereof

    The Regents of the University of California · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9234196

    Compositions and methods for inhibiting expression of transthyretin

    Alnylam Pharmaceuticals, Inc. · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9233108

    Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities

    Almirall, S.A. · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9234179

    Materials and methods for generating pluripotent stem cells

    SHANGHAI UNITED STEM CELL BIOTECHNOLOGY CO., LTD. · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9233926

    Compounds for stem cell differentiation

    ChemRegen, Inc. · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9233168

    Oligomer-opioid agonist conjugates

    Nektar Therapeutics · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9233164

    Water soluble fullerene formulations and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9234187

    Modified zinc finger binding proteins

    Sangamo Biosciences, Inc. · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9234078

    Conjugated gold nanoparticles

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9233095

    Small molecule RNase inhibitors and methods of use

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9233086

    Inhibition of WDR5 interaction with its binding partners

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9233170

    Interfering RNA delivery system and uses thereof

    Arrowhead Research Corporation · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9234016

    Engineered zinc finger proteins for treating trinucleotide repeat disorders

    Sangamo Biosciences, Inc. · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9233121

    Compositions and methods for the treatment of cancer

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9233165

    Oligomer-aryloxy-substituted propanamine conjugates

    Nektar Therapeutics · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9233169

    Oligomer-bis-chromonyl compound conjugates

    Nektar Therapeutics · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9233103

    Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9233085

    Topical application of AMPK activators for pharmacological prevention of chronic pain

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9233162

    High affinity VEGF-receptor antagonists

    The Board of Regents of the University of Texas System · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9233932

    Oligomer-nitroimidazole anti-infective conjugates

    Nektar Therapeutics · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9234198

    Multiple exon skipping compositions for DMD

    Sarepta Therapeutics, Inc. · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9234188

    Modified zinc finger binding proteins

    Sangamo Biosciences, Inc. · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9234017

    Aquaporin-4 peptide compositions and methods of use thereof

    The Regents of the University of California · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9233068

    Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders

    The Regents of the University of California · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9233940

    Cyclic peptidomimetic compounds as immunomodulators

    Aurigene Discovery Technologies Limited · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9234000

    Benzylamine derivatives as inhibitors of plasma kallikrein

    KalVista Pharmaceuticals Limited · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9233973

    Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9233167

    Oligomer-opioid agonist conjugates

    Nektar Therapeutics · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9233927

    Crystals of laquinimod sodium and improved process for the manufacture thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. EP 2964255

    BEHANDLUNG UND VORBEUGUNG VON REMOTER ISCHÄMISCHER REPERFUSION

    CSL BEHRING GMBH [DE] · Granted Wed Jan 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Jan 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9238041

    Methods and compositions for regulating RNA import into mitochondria

    The Regents of the University of California · Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9238639

    Aromatic ring compound

    Takeda Pharmaceutical Company Limited · Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9238625

    Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives

    REVIVA PHARMACEUTICALS, INC. · Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9238838

    Microrna patterns for the diagnosis, prognosis and treatment of melanoma

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9238653

    Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase

    The Board of Regents of the University of Texas System · Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9238676

    Peptide and peptidomimetic inhibitors

    RA PHARMACEUTICALS, INC. · Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9238684

    SPANX-B polypeptides and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9238042

    Antisense modulation of interleukins 17 and 23 signaling

    Sarepta Therapeutics, Inc. · Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9238069

    Method of sensitizing cancer cells to the cytotoxic effects of death receptor ligands in cancer treatment

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9238811

    siRNA phospholipid conjugate

    Northwestern University · Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9238044

    Alkali-free bioactive glass composition

    REG4LIFE REGENERATION TECHNOLOGY, S.A. · Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9238029

    Multiple PPI dosage form

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9238692

    Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9238799

    Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9238153

    Transoral methods and compositions for wrinkle reduction and cosmetic lip and facial augmentation

    Sunny BioDiscovery · Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2036?

1,428 published patents in our USPTO index have expiration dates falling in calendar year 2036.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.